drugset
drugset / Trial / NCT03633591

A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone

NCT03633591 ↗

Phase 1 Completed 12 enrolled Corino Therapeutics, Inc. Quotient Sciences · collab
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to assess the pharmacokinetic profiles of tolcapone in healthy subjects after administration of one or two oral doses of multiple modified release prototype formulations.

Timeline

Start
2018-06-25
Primary completion
2018-10-22
Completion
2018-10-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolcapone Unknown — Oral

Indications

No indication recorded.